Celcuity Inc.: Celcuity Appoints Michael Snitkovsky as VP of Program Management and David Bridge as VP of Quality Assurance and Process Development
MINNEAPOLIS, MN / ACCESSWIRE / November 29, 2021 / Celcuity Inc. (Nasdaq:CELC), a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating
Vicky Hahne Kostenloser Wertpapierhandel Robert Uhl Michael Snitkovsky Brian Sullivan Program Management
Source: finanznachrichten.de